Healthy Skepticism Library item: 5242

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Mossinghoff GJ.
Drug labelling in developing countries.
Lancet 1993 Aug 28; 342:(8870):556-7

Abstract:

The study by the Office of Technology Assessment (OTA) that compared drug labelling in the United States and four developing countries is flawed and inaccurate. The OTA merely compiled the differences between labels in the different countries despite the fact that labels differ for valid reasons. The OTA also failed to recognize that U.S. labels are a function of the American medical, regulatory and legal environment.

Keywords:
Developing Countries* Drug Labeling/standards* Humans United States United States Office of Technology Assessment *letter to the editor/United States/developing countries/Office of Technology Assessment/industry perspective/ labeling/ Pharmaceutical Manufacturers Association (US)/ATTITUDES REGARDING PROMOTION: INDUSTRY/EVALUATION OF PROMOTION: COMPARISON BETWEEN DEVELOPING AND DEVELOPED COUNTRIES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES